| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" standalone="no" encoding="windows-1252"?> |
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b --> |
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co --> |
<!-- Field: Doc-Info; Name: Source; Value: Evolutionary Genomics, Inc. 9%2D30%2D19 10Q.xfr; Date: 2019%2D10%2D17T15:23:49Z --> |
<!-- Field: Doc-Info; Name: Status; Value: 0x800B0000 --> |
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-daei" xlink:href="fnam-20190930.xsd#fnam-daei" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheets" xlink:href="fnam-20190930.xsd#AndConsolidatedBalanceSheets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheetsParenthetical" xlink:href="fnam-20190930.xsd#AndConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfOperations" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementsOfOperations" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementOfStockholdersEquity" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementOfStockholdersEquity" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfCashFlows" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementsOfCashFlows" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/NatureOfBusiness" xlink:href="fnam-20190930.xsd#NatureOfBusiness" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/NewAccountingStandards" xlink:href="fnam-20190930.xsd#NewAccountingStandards" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurements" xlink:href="fnam-20190930.xsd#FairValueMeasurements" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipment" xlink:href="fnam-20190930.xsd#PropertyAndEquipment" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssets" xlink:href="fnam-20190930.xsd#IntangibleAssets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStock" xlink:href="fnam-20190930.xsd#Disclosure-CommonStock" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensation" xlink:href="fnam-20190930.xsd#Stock-basedCompensation" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingencies" xlink:href="fnam-20190930.xsd#CommitmentsAndContingencies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactions" xlink:href="fnam-20190930.xsd#RelatedPartiesAndTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Concentrations" xlink:href="fnam-20190930.xsd#Concentrations" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcern" xlink:href="fnam-20190930.xsd#LiquidityAndGoingConcern" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-se" xlink:href="fnam-20190930.xsd#fnam-se" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-soapadobp" xlink:href="fnam-20190930.xsd#fnam-soapadobp" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsTables" xlink:href="fnam-20190930.xsd#FairValueMeasurementsTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentTables" xlink:href="fnam-20190930.xsd#PropertyAndEquipmentTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssetsTables" xlink:href="fnam-20190930.xsd#IntangibleAssetsTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsTables" xlink:href="fnam-20190930.xsd#StockholdersEquityAndWarrantsTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationTables" xlink:href="fnam-20190930.xsd#Stock-basedCompensationTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/BusinessActivityDetails" xlink:href="fnam-20190930.xsd#BusinessActivityDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsDetails" xlink:href="fnam-20190930.xsd#FairValueMeasurementsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentDetails" xlink:href="fnam-20190930.xsd#PropertyAndEquipmentDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssetsDetails" xlink:href="fnam-20190930.xsd#IntangibleAssetsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStockDetails" xlink:href="fnam-20190930.xsd#Disclosure-CommonStockDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:href="fnam-20190930.xsd#StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationNarrativeDetails" xlink:href="fnam-20190930.xsd#Stock-basedCompensationNarrativeDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:href="fnam-20190930.xsd#Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingenciesDetails" xlink:href="fnam-20190930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactionsDetails" xlink:href="fnam-20190930.xsd#RelatedPartiesAndTransactionsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcernDetails" xlink:href="fnam-20190930.xsd#LiquidityAndGoingConcernDetails" xlink:type="simple"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-daei" xlink:title="00000001 - Document - Document and Entity Information"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheets" xlink:title="00000002 - Statement - Condensed and Consolidated Balance Sheets"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed and Consolidated Balance Sheets (Parenthetical)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - Condensed and Consolidated Statements of Operations"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementOfStockholdersEquity" xlink:title="00000005 - Statement - Condensed and Consolidated Statement of Stockholders' Equity"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed and Consolidated Statements of Cash Flows"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapPaymentsToAcquireTradingSecuritiesHeldforinvestment"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Business Activity"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/NewAccountingStandards" xlink:title="00000009 - Disclosure - New Accounting Standards"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurements" xlink:title="00000010 - Disclosure - Fair Value Measurements"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipment" xlink:title="00000011 - Disclosure - Property and Equipment"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssets" xlink:title="00000012 - Disclosure - Intangible Assets"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStock" xlink:title="00000013 - Disclosure - Stockholders' Equity and Warrants"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensation" xlink:title="00000014 - Disclosure - Stock-Based Compensation"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactions" xlink:title="00000016 - Disclosure - Related Parties and Transactions"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Concentrations" xlink:title="00000017 - Disclosure - Concentrations"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcern" xlink:title="00000018 - Disclosure - Liquidity and Going Concern"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-se" xlink:title="00000019 - Disclosure - Subsequent Events"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-soapadobp" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsTables" xlink:title="00000021 - Disclosure - Fair Value Measurements (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssetsTables" xlink:title="00000023 - Disclosure - Intangible Assets (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsTables" xlink:title="00000024 - Disclosure - Stockholders' Equity and Warrants (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationTables" xlink:title="00000025 - Disclosure - Stock-Based Compensation (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/BusinessActivityDetails" xlink:title="00000026 - Disclosure - Business Activity (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies (Other) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies (Property and Equipment) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Intangible Assets) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Net Loss Per Common Share) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsDetails" xlink:title="00000031 - Disclosure - Fair Value Measurements (Details)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsFairValueDisclosure" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentDetails" xlink:title="00000032 - Disclosure - Property and Equipment (Details)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssetsDetails" xlink:title="00000033 - Disclosure - Intangible Assets (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStockDetails" xlink:title="00000034 - Disclosure - Stockholders' Equity and Warrants (Narrative) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:title="00000035 - Disclosure - Stockholders' Equity and Warrants (Summary of Warrants Activity) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationNarrativeDetails" xlink:title="00000036 - Disclosure - Stock-Based Compensation (Narrative) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:title="00000037 - Disclosure - Stock-Based Compensation (Summary of Stock Options Activity) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000038 - Disclosure - Commitments and Contingencies (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactionsDetails" xlink:title="00000039 - Disclosure - Related Parties and Transactions (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcernDetails" xlink:title="00000040 - Disclosure - Liquidity and Going Concern (Details)"/> |
| </link:linkbase> |